Nap M, Brockhoff G, Brandt B, Knuechel R, Leers M P, Schmidt H, De Angelis G, Eltze E, Semjonow A
Atrium Medical Centre Heerlen, Department of Pathology, The Netherlands.
Virchows Arch. 2001 May;438(5):425-32. doi: 10.1007/s004280000369.
This meeting report summarizes the presentations of three different groups that are active in the field of flow cytometry (FCM) in relation to diagnosing and classification of proliferative disorders. The report starts with the contribution from Regensburg about the developments in DNA FCM, the progression to dual parameter determinations, and combination of immunophenotyping in combination with DNA. In the second part, the use of FCM for the detection of isolated tumor cells in the peripheral blood from patients with prostate or breast cancer is discussed in a contribution from Münster. In the third part, from Heerlen, the use of multi-parameter FCM on formalin-fixed paraffin-embedded tissues from solid tumors is discussed as a new development and application in routine surgical pathology.